Alexiadis M, Mamers P, Chu S, Fuller P J
Departments of Medicine and Obstetrics and Gynaecology, Prince Henry's Institute of Medical Research and the Monash University, Monash Medical Centre, Clayton, Victoria, Australia.
Int J Gynecol Cancer. 2006 Nov-Dec;16(6):1973-9. doi: 10.1111/j.1525-1438.2006.00724.x.
The insulin-like growth factor (IGF) system plays an important role in folliculogenesis. It is also thought to contribute to the pathogenesis of many cancers, including those of the ovarian epithelium. In the human follicle, the predominant IGF is IGF-II and its actions are modulated by insulin-like growth factor-binding protein-4 (IGFBP-4), the IGFBP-4 protease, and the pregnancy-associated plasma protein-A (PAPP-A). These peptide components are synthesized by the granulosa cells of the developing follicle. The aim of this study was to characterize the expression of these components of the IGF system in granulosa cell tumors (GCT) of the ovary. IGF-I, IGF-II, IGFBP-4, and PAPP-A gene expression was determined in a panel of GCT and compared to the levels in normal ovary and in epithelial ovarian tumors. Although both the IGF-I and IGF-II genes were expressed in the GCT, the levels were lower than in the other tissue groups. IGFBP-4 expression was also low in the GCT, whereas PAPP-A gene expression was highest in the GCT. These findings were unexpected given the prominent role this signaling system plays in normal granulosa cells. In conclusion, these observations suggest that the IGF system may have a limited role in the pathogenesis of GCT with PAPP-A subserving a function other than IGFBP-4 proteolysis.
胰岛素样生长因子(IGF)系统在卵泡发生过程中发挥着重要作用。它也被认为与包括卵巢上皮癌在内的许多癌症的发病机制有关。在人类卵泡中,主要的IGF是IGF-II,其作用受到胰岛素样生长因子结合蛋白-4(IGFBP-4)、IGFBP-4蛋白酶和妊娠相关血浆蛋白-A(PAPP-A)的调节。这些肽成分由发育中卵泡的颗粒细胞合成。本研究的目的是表征IGF系统这些成分在卵巢颗粒细胞瘤(GCT)中的表达。在一组GCT中测定了IGF-I、IGF-II、IGFBP-4和PAPP-A的基因表达,并与正常卵巢和上皮性卵巢肿瘤中的水平进行比较。虽然IGF-I和IGF-II基因在GCT中均有表达,但水平低于其他组织组。GCT中IGFBP-4的表达也较低,而PAPP-A基因表达在GCT中最高。鉴于该信号系统在正常颗粒细胞中发挥的重要作用,这些发现出乎意料。总之,这些观察结果表明,IGF系统在GCT的发病机制中可能作用有限,PAPP-A发挥的功能并非IGFBP-4蛋白水解作用。